Validation of fluid-derived biomarkers for the prediction and prevention of brain disorders
This Horizon Europe program, 'Validation of fluid-derived biomarkers for the prediction and prevention of brain disorders,' aims to significantly advance the understanding and management of high-burden brain disorders. It seeks to validate fluid-derived biomarkers for early detection and personalized treatment, fostering collaborative research across scientific, clinical, and patient communities. The initiative emphasizes the development of cost-efficient diagnostic tools and leverages existing data infrastructures to improve global health outcomes.
Who is Funded
This section summarizes who is generally eligible for funding, details the target groups, geographical scope, and the program's overarching objectives. It includes defining characteristics of intended beneficiaries and strategic aims.
What is Funded
This section provides details on eligible project types, thematic areas, and activities. It clarifies covered costs and the typical developmental stage of supported projects, including specific examples or exclusions.
Type and Scope of Funding
This section provides details on the nature of financial support, including the types of funding, amounts, and all relevant financial parameters.
Conditions and Requirements
This section outlines key rules, regulations, and specific conditions for applicants and beneficiaries. It covers application terms, collaboration rules, budget stipulations, and other important provisions.
Application Procedure
This section guides through the application process, covering preparation, submission, documentation, and how decisions are made and communicated. It includes all relevant procedural details and timelines.
Legal Basis
This section outlines the foundational legal and official documents that authorize, establish, and govern the funding program, identifying its primary source of legitimacy and significant overarching regulations.
Similar Programs
Funding Overview
Funding Status:
Closed
Maximum Amount:
6,000,000 € to 8,000,000 €
Allocated Budget:
EUR 25,000,000
Award Channel:
Framework Programme Call
Region:
European Union, Countries associated with Horizon Europe, United States of America
Sectors:
Healthcare, Medical Technology, Pharmaceutical Industry, Research and Development, Information and Communication Technology, Software Development
Beneficiaries:
Patients and caregivers, healthcare providers, and citizens.
Application Type:
Consortium Required
Funding Stages:
Applied Research, Experimental Development, Prototyping, Pilot Testing, Product Development, Commercialization, Other
Funding Provider
Program Level:
European Union
Funding Body:
European Commission
Managed By:
European Health and Digital Executive Agency (HaDEA)
Website: